Basal SOD2 expression may hence be increased in cancer types that display high levels of TP53 mutation, such as ovarian high-grade serous adenocarcinomas [93] or where TP53 activity is lost during tumor progression [87]. The gene discussed is TP53; the disease is neoplasm.